联影医疗(688271):UNITEDIMAGINGHEALTHCARE2025ESGREPORT
原标题:联影医疗:UnitedImagingHealthcare2025ESGReport Activities Management discipline Supervision of Listed 116 Preventing Data Risks Companies No. 14 - Sustainable 95 Engaging in Medical Health 98 Undertaking Environmental 119 Implementing Responsible Development Report (Provisional) Knowledge Protection Marketing 125 GRI Standards and United Nations ※※2200226600661188 下下午午 ※※ 演演示示用用水水印印 ※※2200226600661188 下下午午 ※※ 演演示示用用水水印印 ※※2200226600661188 下下午午 ※※ 演演示示用用水水印印 ※※2200226600661188 下下午午 ※※ 演演示示用用水水印印 ※※2200226600661188 下下午午 ※※ 演演示示用用水水印印 ※※2200226600661188 下下午午 ※※ 演演示示 The 2025 Environmental, Social and Governance for Self-Regulation of Listed Companies—Sustainability the Shanghai Stock Exchange and the Group for easy Report of Shanghai United Imaging Healthcare Co., Report (Trial) of the Shanghai Stock Exchange (SSE), access by global stakeholders. This report has been Ltd., as the fourth ESG report released by the Group, the standards of the Global Reporting Initiative reviewed and approved for publication by the Board comprehensively demonstrates the practices (GRI), and the guidelines of the United Nations of Directors on April 27, 2026. We are committed and achievements in the environmental, social Sustainable Development Goals (SDGs). The report to continuously improving the quality of the report and governance fields in 2025. This report aims covers the entire year of 2025 in terms of main and actively promoting the implementation of the to provide transparent and detailed information business operations, with appropriate retrospection sustainable development strategy. We also sincerely disclosure to the stakeholders, including the of historical data to enhance comparability. All data welcome valuable suggestions and feedback from all ※20260618 下午 3※ ※ 演示用水印 ※20260618 下午 3※ ※ 演示用水印 ※20260618 下午 3※ ※ 演示用水印 ※20260618 下午 3※ ※ 演示用水印 ※20260618 下午 3※ ※ 演示用水印 ※20260618 下午 ※ 演示 Management Statement In 2025, the global healthcare industry standed at As a medical technology enterprise deeply engaged The responsibility of healthcare lies not only in consolidated our complete technological ecosystem a critical juncture featuring the in-depth integration in global healthcare, we always evaluate our minimizing impacts, but more importantly in creating spanning “core components, complete systems and of sustainable development with new quality sustainability performance against the highest value. intelligent platforms.” Empowering all products with productive forces. At the intersection of these two standards. In the past year, we have systematically AI, we strike an optimal balance between efficiency, forces of the times, we have further deepened our advanced the development of the carbon emission We focus closely on where advanced technologies accuracy and accessibility for imaging equipment. understanding and practice of ESG. management system, conducting cradle-to-gate can ultimately reach and whom they can benefit. We fulfill our commitment to universal health equity carbon footprint assessment covering the entire In 2025, United Imaging Healthcare continued through technological innovation, transforming The medical profession inherently bears the weight value chain from raw material procurement and to extend high-quality medical resources to advanced medical technologies from being available of life, equity and trust. The fundamental nature of component production to complete equipment grassroots communities and broader regions. to being accessible. As our digital and intelligent PET/ healthcare is the most profound manifestation of assembly. We have translated green concepts In China, addressing the critical area of county- CT systems continue to enter global markets, we drive ESG. Fifteen years ago, United Imaging Healthcare into verifiable practical actions. Our CT product level healthcare, we are building a system-wide not only the generational upgrading of local medical embarked on its journey with the mission of " To has become the first in China to obtain ISO 14067 framework grounded in institutional development, equipment, but also the overall improvement of Bring Equal Healthcare for All". For us, ESG has never product carbon footprint verification, setting a centered on capacity building, and anchored in talent diagnostic and therapeutic capabilities. been an optional extra task at a certain stage of benchmark for green development across the cultivation. Leveraging digital and intelligent medical development; instead, it is an inherent requirement industry. technologies, we are developing integrated solutions If technology determines the height of an industry, deeply embedded in our business model and for specialized diseases and regional connectivity. then talent defines its depth and sustainability. We corporate culture, as well as an indispensable path Environmental responsibility is never a cost By collaborating with primary-care administrators, have consistently improved our talent development that runs through the entire development of the constraint, but a core capability that underpins the we are driving a comprehensive upgrade of the system, established multi-level leadership training Company. enterprise’s long-term resilience through economic healthcare service system and accelerating the and high-potential talent reserve mechanisms, and cycles. We integrate low-carbon concepts into the structural expansion and balanced allocation of formed a dynamic talent supply chain to support the Over fifteen years of development, United Imaging entire lifecycle of R&D, manufacturing, operations high-quality resources. Globally, we leverage our full long-term development of the industry. Meanwhile, we Healthcare has achieved continuous breakthroughs and supply chain management. We promote eco- range of AI-native high-end medical equipment as actively promote industry-academia-research-medical in independent innovation of core technologies, design at the source to achieve more energy- a connecting force, scientific research collaboration collaboration, build joint laboratories, and cultivate global market expansion, and the development of efficient equipment, continuously upgrade our as a bridge, and talent development as a key driver interdisciplinary professionals with both industrial sustainable governance capabilities. This growth has green manufacturing system, expand the application to extend our collaborative reach to greater depths and clinical expertise to address the industry-wide brought us not only business expansion, but also a of clean energy, and advance energy-saving and broader horizons, thereby promoting mutual shortage of specialized talents. In addition, we foster profound respect for the principle that "with great transformation and technological innovation. We progress in medical cooperation and equitable a diverse and inclusive workplace, establish multi-level power comes great responsibility". also accelerate the building of a “resilient, green and access to healthcare worldwide. communication channels, and continuously optimize transparent” global supply chain. Amid complex compensation, welfare, occupational health and safety While large-scale medical equipment shoulders geopolitical environments and escalating climate Technological innovation serves as the core engine protection. In 2025, the Company granted restricted the vital mission of safeguarding human life, it also risks, we consistently help global customers reduce connecting green development with inclusive shares to core key employees, forging an even closer The long-term vision of healthcare ultimately relies robust governance system enables us to respond every investment in green low-carbon development, for customers, employees, society and global on robust systems and mechanisms to ensure proactively to external changes with clear guidelines inclusive healthcare, corporate governance and stakeholders. Together, we protect human health sustainability. In the long-cycle healthcare industry, and solid foundations, ensuring steady and talent cultivation will build the enterprise’s resilience and build a sustainable future for all. moving steadily forward matters far more than sustainable corporate development. and competitiveness to navigate future cycles, moving fast. United Imaging Healthcare continues to and ultimately deliver long-term value returns to optimize its modern corporate governance structure, Looking ahead, United Imaging Healthcare will customers, employees and society. strictly complies with regulatory requirements always prioritize our original aspiration of healthcare and market rules, upholds business ethics, and regard ESG as the fundamental approach for We will continue to drive medical transformation strengthens risk management and information long-term corporate development. This represents through innovation, fulfill our social responsibilities security capabilities, and supports global business not only a commitment to social responsibility, but amid the changing times, and create lasting value layout with international compliance standards. A also a strategic investment in the future. We believe About the Report United Imaging Healthcare Co., Ltd. has prepared the Basis of Preparation Reporting Scope Access to the Report Report in light of relevant regulatory requirements The report is prepared in accordance with the Guidelines and Boundary The report is published in both English and simplified and reporting standards. This is the fourth ESG No. 14 for Self-Regulation of Listed Companies—Sustainability Chinese. In case of any inconsistency in contents, the Report released by United Imaging Healthcare The content of the report covers all main businesses of Report (Trial) of the Shanghai Stock Exchange (hereinafter simplified Chinese version shall prevail. To support the Group. Unless otherwise stated, the performance Co., Ltd., which aims to objectively, standardly , referred to as the “SSE Guidelines”) and the Sustainability environmental protection, the report is published in indicators in the report cover all offices/production/R&D transparently and comprehensively disclose to Reporting Standards of the Global Reporting Initiative (GRI electronic form, which can be accessed and downloaded sites of the Group. Standards) issued by the Global Sustainability Standards on the SSE Information Disclosure Website (http://www. stakeholders including governments and regulatory Board (GSSB) and the United Nations’ Guide for Business sse.com.cn/disclosure/listedinfo/announcement/) or authorities, shareholders and investors, customers, Action on the Sustainable Development Goals (SDGs). This United Imaging Healthcare’s official website (https://www. suppliers and partners, employees, communities report aims to continuously improve the disclosure united-imaging.com/).and media, the work carried out and achievements transparency of the Group’s sustainability-related made by the Group in environmental, social and information and respond to the stakeholders’ concern Suggestions are welcomed through the following contact about the Group’s ESG management and performance. details. Your opinions will assist us in further refining the governance (hereinafter referred to as “ESG”) aspects report and in enhancing the Group’s ESG performance. in 2025. Tel: +86(21)-67076658 E-mail: [email protected] Abbreviation Address: 2258 Chengbei Road, Jiading District, Shanghai 201807, China. Abbreviation Reference The Group, We, the Company, United Imaging Healthcare, UIH Shanghai United Imaging Healthcare Co., Ltd. and its subsidiaries Changzhou Manufacturing Facility United Imaging (Changzhou) Healthcare Co., Ltd.Wuhan Manufacturing Facility Wuhan United Imaging Healthcare Co., Ltd.Report Disclosure US Manufacturing Facility United Imaging Healthcare North America, Inc.United Imaging Healthcare North America LLC Data and cases in the report are derived from official UIH Technologies LLC documents and statistical reports of the Group, and reviewed by relevant departments. The currency in the report is RMB. As some amounts and percentage numbers in the report have been rounded, the total amounts may Reporting Period Confirmation and Approval not be the sum of the figures in some tables. The report is released annually. The Report was approved by the Board of Directors (“the Board”) of the Group on April 27, 2026.The Board commits Reporting timescale: From January 1, 2025 to December to supervising the content of the Report and ensuring 31, 2025. To enhance the comparability and completeness Key Performance Indicators in 2025 Financial Performance The total operating revenue The revenue from The year-on-year growth rate Proportion of overseas business of the company overseas business of the overseas business in the total revenue increased toIndicators The Group continued to invest in key areas including % % 13.80 billion 3.431 billion 51.39 24.86 R&D and innovation, technology upgrading, quality control, marketing, customer service, and supply chain management. Through ongoing optimization, we steadily enhanced the quality of our products and services, and shaped a premium brand image, laying a solid foundation for the Group’s sustainable The revenue from service The year-on-year growth rate Proportion of service business Proportion of overseas service and stable operations. business was of the service business in the total revenue revenue increased by% % % 1.708billion 25.96 12.38 52.82 Net profit attributable to The gross profit The basic earnings The investment shareholders of the Group margin per share in R&D % RMB per share million billion 1.869 47.01 2.28 2.621 Social Performance Indicators Upholding the mission “To Bring Equal Healthcare for All”, the Group actively pursued product innovation and continuously improved the efficiency of medical resources. These efforts were dedicated to promoting accessible and inclusive medical services. Moreover, the Group enthusiastically participated in philanthropic activities and demonstrated deep care for employee development and community well-being. This helped us comprehensively fulfill our social responsibilities.Cumulative total of patent applications Total employees in more than 40 branches, Total employee training hours subsidiaries and offices worldwide 10,190 294,576.58 8,700+8,700+ Total number of training participants was 411,730, and the coverage During the reporting period, rate of training for employees was 100%, encompassing various types more than 1,000 new employees were recruited of training such as business ethics, responsible marketing, information security, and quality safety Number of invention patent applications Number of R&D employeesDuring the reporting period, the number of quality audits and inspections by supervisory and auditing 8,385 3,4973,497 organizations accepted and passed accumulated 3,993 invention patents had been granted 32 Achieving 100% compliance with regulatory Total certified and launched products The business covered requirements in target markets 获证并推向市场 150+ 1100+00+ During the reporting period, public welfare donations 75 products obtained CE MDD/MDR certifications countries and regions示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午※ 演示 ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 ※ 演示 Environmental Performance Indicators The Group keeps promoting green and low-carbon development by implementing diverse energy-saving renovations and exploring innovative green production, thereby contributing to the steady advancement of the “dual carbon” strategic goal. Greenhouse gas (GHG) emission reduction targets (Scope 1 and Scope 1 and Scope 2 (market-based) Down by 5,917.65 tCO e, compared to the 2 Scope 2): using 2023 as the baseline year, to achieve reduction GHG emissions baseline yearin carbon emission intensity per unit of revenue by 2035 % -7.80 tCO e 69,958.32 2 % 50 Scope 3 GHG emissions Scope 1 and Scope 2 (market-based) GHG emissions intensity Energy consumption tCO e tCO e/RMB million revenue GJ 465,564.28 2 5.06 2 476,411.44 Down by 23.88% compared to the baseline year Water consumption Water consumption intensity Energy consumption intensity tonnes tonnes/RMB million revenue GJ/RMB million revenue 331,813 24.01 34.47 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午※ 演示 ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 ※ 演示 About United Imaging Healthcare United Imaging Healthcare (stock code: 688271. life science instruments, and innovative solutions VISION SH) was established in 2011, with its headquarters covering the entire value chain from basic research located in Shanghai. Supported by our global to clinical research and translational medicine. As Leading Healthcare Innovation strategic footprint, we have established regional of the end of the reporting period, the Group had headquarters and R&D centers in multiple countries, cumulatively launched more than 150 products MISSION including the United States, Singapore, and the to the market, which were used by over 16,400 Netherlands. We have also arranged production medical and scientific research institutions in 100 To Bring Equal Healthcare for All facilities in Shanghai, Changzhou, Wuhan, and countries and regions around the world. Through Houston (USA), progressively building an integrated deep collaboration with global universities, hospitals, PROMISE global network for research, manufacturing, and research institutions, and industrial partners, we service. continuously break through the boundaries of Passion for Change technological innovation, and advance precision For more information, please visit the Company’s official website and official WeChat. We are committed to providing global customers medicine and forward-looking scientific research. Official website: www.united-imaging.com with a full range of self-developed, high-performance These efforts enhance the accessibility of high-end diagnostic and therapeutic imaging equipment, medical devices and services worldwide.2023 2020 United Imaging Healthcare United Imaging Healthcare launched nearly The Company used its professionalism and hard 120 products on the market, with operating work to fulfill the mission and responsibility as a Development Milestones revenue exceeding RMB 10 billion, and more large Chinese enterprise, by sending emergency than 30 subsidiaries and offices worldwide. We aid to all provinces in China and more than 30 made our debut at the European Congress of countries around the world, fighting against the Radiology (ECR), marking our official entry into global public health challenges. the European market. 2011 2016 Shanghai United Imaging Healthcare Co., Ltd. Changzhou Manufacturing Facility was formally was formally founded. put into use, functioning as an intelligent medical device manufacturing base, covering an area of approximately 230,000 square 2024 meters. 2021 2013 The Company established the European Wuhan Manufacturing Facility was officially headquarters in Rotterdam, the Netherlands. By opened, and the base integrates R&D, production North America Research and Development enhancing our marketing, service, and research and operation, with a total area of more than Center was established in Houston, Texas, USA. and development capabilities, we have been 2017 200,000 square meters. accelerating globalization and expanding the Series A financing of RMB 3.333 billion was brand’s influence in the European market, aiming completed, with a post-investment valuation of to provide regional customers with higher-quality approximately RMB 33.333 billion, marking the 2014 products and services. largest single private financing in China’s medical UIH High-End Medical Device Industrial Base was device industry in the current year. built in Shanghai, covering an area of 120,000 square meters. It provides powerful support to the upgrading and development of China’s healthcare industry. 2025 2022 2018 The brand and full product line of United Imaging The launch of the uSONIQUE series of ultrasound Shanghai United Imaging Healthcare Co., Ltd. UIH North American Headquarters was Healthcare were officially announced and successfully completed the Company’s was listed on Science and Technology Innovation established in Houston, Texas, with an area of entered the market. comprehensive imaging product portfolio. That Board (STAR Market) of Shanghai Stock Exchange. approximately 9,000 square meters, providing same year, the uCT Ultima, China’s first Photon- R&D, production, marketing functions. Counting CT, was officially launched, filling a technological gap in the domestic market. The Company debuted at the Radiological Society Thanks to breakthroughs in core technologies, 2015 of North America (RSNA) with its full line of the Company’s entire product portfolio and nine products, and its exhibition scale, exhibit variety U+ online medical strategy was established to specialized product lines ranked first in China’s and number of listed papers hit the historical provide a series of digital medical solutions Awards and Recognitions Innovation Awards and Recognitions Issuing Authority The project “Key Technologies and Applications of Rapid Magnetic Resonance Imaging for Precise Diagnosis and Treatment of Ministry of Education of the People's Republic of China Cerebrovascular Diseases” won the First Prize of the Engineering Technology Research Achievement Award under the 2024 Excellent Scientific Research Achievement Award of the Ministry of Education (Natural Science and Engineering Technology) The project "Independent R&D and Industrialization of Multimodal Molecular Imaging Equipment" won the First Prize of Shanghai Municipal People's Government Shanghai Science and Technology Progress Award uMammo, a mammography system, has become the only mammography device in the world to receive a 5-star rating Emergency Care Research Institute (ECRI) certification The paper Performance Characteristics of NeuroEXPLORER, a Next-Generation Human Brain PET/CT Scanner, co-completed Journal of Nuclear Medicine (JNM) by the NeuroEXPLORER team led by Dr. Hongdi Li, Chief Scientific Officer of United Imaging Healthcare, was selected by the editors and won two awards: the 2024 “Best Clinical Paper” and “Paper of the Year” Projects including “Popularization and Application of Photon Counting Spectral CT” and “R&D and Popularization of Innovative Ministry of Industry and Information Technology of the People's Republic Solutions for Intelligent Stereotactic Radiotherapy Systems” had been successfully selected into the 2025 High-end Medical of China, National Health Commission of the People's Republic of China, Equipment Popularization and Application Program National Medical Products Administration of the People's Republic of China uCT SiriuX, the industry's first dual-wide-body dual-source CT, had officially obtained approval for market launch as an National Medical Products Administration (NMPA) innovative medical device from the National Medical Products Administration (NMPA) uIPW (Intelligent Physician Workspace), China’s first system equipped with AI contouring function covering multiple target National Medical Products Administration (NMPA) regions and organs, has officially obtained the Class III Medical Device Certification from the National Medical Products Administration (NMPA)ESG-related Awards and Recognitions Issuing Authority MSCI ESG Rating Awarded Rating AA MSCI Carbon Disclosure Project (CDP) Climate and Water Carbon Disclosure Project (CDP) Questionnaire 2025 Rating B (Management Level) CSI ESG Rating AAA China Securities Index Co., Ltd. S&P Global 2026 S&P Global Sustainability Yearbook (China Edition) – Selected Enterprise S&P Global 2025 Corporate Sustainability Assessment (CSA) – Industry Top Improver Shanghai Securities News 2025 ”SSE Eagle · Gold Quality” ESG Award Outstanding Award for Sustainability Information Disclosure Cailianshe Annual ESG Star of Excellence——"Changes in ‘County’ Area SAILING HEALTH - Mobile Healthcare Tours”Corporate Influence and Employer Branding-relatedGuided by the mission, “To Bring Equal Healthcare for All”, United Imaging Healthcare is committed to “Leading Healthcare Innovation”. We actively fulfill our brand commitment to “perceive, create, and engage with compassion”. By establishing a clear sustainability strategy and a robust management system, we deeply integrate ESG principles into every aspect of our business operations. We strive not only to achieve business value growth but also to empower the healthcare industry and promote the sustainable development of society.ESG Management System We continuously optimize our ESG governance structure by constructing members is directly linked to “ESG performance improvement”. This cash dividends may be deducted. If the annual distribution has already a three-level governance framework spanning “decision-making, demonstrates our commitment to integrating ESG performance into been completed, the deduction will be applied in the following year. management, and execution levels” with well-defined responsibilities management development. We continuously strengthen incentive and restraint mechanisms for and authorities. This establishes a coordinated mechanism where the the management to ensure their diligence and responsibility, thereby decision-making level formulates the overall strategy, the management At the same time, in accordance with internal regulations such as the promoting the Group’s steady development. level oversees the overall planning, and the execution level ensures Cadre Management System and the Authority and Responsibility Matrix, the effective implementation, thereby providing a robust systemic guarantee Group strengthens shareholder oversight of executive compensation. The Management Committee’s evaluation weight tied for sustainable development. We also actively promote the development of a compensation clawback to "ESG performance improvement" is and malus mechanism to ensure that the actions of management are To ensure that the leadership team’s objectives are closely aligned aligned with the interests of the Group and shareholders. If directors, with the vision and strategic goals for sustainable development, we supervisors, or senior management cause losses to the Group or % 5 incorporate sustainable development targets into the individual investors due to their actions, they are legally liable for compensation. evaluation system for members of the Management Committee. In such cases, United Imaging Healthcare reserves the right to suspend Specifically, 5% of the evaluation weight for the Management Committee their salaries and allowances. For those with indirect shareholdings, 决策层Decision-making level Management level Execution levelThe Board of Directors (hereinafter referred to as the Board) of United The Group’s management, guided by the Board and the Strategy Guided by the ESG management concept, all functional departments Imaging Healthcare serves as the highest governing body for the and Social Responsibility Committee, is responsible for the detailed and branches work in concert to implement the Group’s ESG strategy. Group’s ESG management, responsible for devising the overarching management of various ESG tasks. Based on the overall ESG planning, They support the execution of various ESG tasks, such as climate ESG strategic plan and conducting regular evaluations to ensure they drive relevant departments to execute specific assignments and change actions, innovation-driven development, product quality and the effective and high-quality management of ESG initiatives. The regularly report task progress to the Board and the Strategy and Social safety, human capital development, and business ethics and compliant Strategy and Social Responsibility Committee, operating under Responsibility Committee. This ensures the steady advancement of operations, according to the requirements of management. the purview of the Board, which reports to the Board regularly. ESG initiatives including climate change actions, innovation-driven The Committee is responsible for conducting research and putting development, product quality and safety, human capital development, forward recommendations on ESG decisions and policies, supervising and business ethics and compliant operations. and evaluating the Group’s performance in various ESG aspects including climate change response, innovation, product quality and 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午※ 演示 ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 ※ 演示 ESG Risk and Opportunity Management 示用水印 ※ ※ 演示用水印 ※ ※ 演示用水印 ※ ※ 演示用水印 ※ ※ 演示用水印 ※ ※ 演示用水印 ※Identifying material issues Monitoring dynamic changes Implementing response actionswe systematically assess sustainability-related topics, considering we have established a dynamic tracking and monitoring mechanism to we formulate and execute targeted measures based on monitoring internal business expansion dynamics, shifts in external policies gather information on sustainability-related topics, and to assess their outcomes. On one hand, we adopt effective prevention and control and regulations, and market trends. This allows us to identify potential impacts, risks, and opportunities for the Company, thereby measures to minimize the adverse effects of risks. On the other hand, sustainability-related risks, opportunities, and their impacts. staying abreast of any updates in a timely manner. we keenly identify and seize opportunities to support the Company’s growth, ensuring that our sustainability management efforts progress steadily. 示用 ※20260618 下午 3※ 演示用 ※ 演示用水印 ※20260618 下午 3※ 演示用 ※ 演示用水印 ※20260618 下午 3※ 演示用 ※ 演示用水印 ※20260618 下午 3※ 演示用 ※ 演示用水印 ※20260618 下午 3※ 演示用 ※ 演示用水印 ※20260618 下午 ※ 演示 interests of shareholders. For more information, please refer to the requirements and centered on professional improvement and ※ Board Independence compliance training, we systematically organize multi-dimensional Independent Director Work System disclosed by the Company on the website of the Shanghai Stock Exchange (www.sse.com.cn). training for Board members. The content covers both fundamental compliance areas such as national policies, securities-market and Diversity United Imaging Healthcare consistently regards the Board’s diversity laws and regulations, market operation mechanisms, and internal and professionalism as a vital foundation for the Company’s rules, and ESG-related core topics such as climate change. These sustainable development and sound governance. The Company efforts help us effectively raise the compliance awareness and United Imaging Healthcare places high importance on the continuously builds a diverse and inclusive structure in terms of performance capabilities of Board members. In 2025, the Company’s independence of its directors and continuously improves the working gender, age, cultural background, and professional experience. Board of Directors participated in a total of 18 annual and regular mechanism for independent directors, striving to ensure fair and This multi-dimensional perspective and rich expertise ensure training sessions covering multiple topics including United Imaging well-founded decision-making of the Board. In 2025, the Company comprehensive and well-founded complex decision-making and Healthcare’s carbon targets and carbon neutrality plan, corporate resolved that Mr. Wang Shaofei would continue to serve as the strategic planning. Board members possess diverse nationalities culture discussions, corporate strategic development, interpretation Lead Independent Director for the second term of the Board. This and cross-cultural backgrounds. Their expertise spans fields such as of the Code of Corporate Governance for Listed Companies and decision was made in accordance with the Board Audit Committee biomedical engineering, physics, law, and financial management, and compliance practices, aiming to continuously enhance the Board’s Work Rules, the Board Strategy and Social Responsibility Committee they have professional experience at globally leading enterprises and professional capabilities in sustainable development and corporate Work Rules, the Independent Director Work System, the Independent academic institutions. This diversity and professionalism not only governance. Through systematic training and thematic seminars, Director Special Meeting System, and other relevant provisions. ensures that the Group’s policies align with international standards the Board’s strategic guidance and oversight functions in carbon As stipulated by these policies, the Lead Independent Director and best practices, but also enables effective oversight and guidance management, compliance governance and sustainable development is responsible for convening and presiding over independent of the management, enhancing governance quality and transparency. issues were further strengthened to ensure that relevant issues directors’ special meetings, soliciting suggestions from independent We also attach importance to advancing gender diversity. The are fully deliberated and effectively advanced at the Board level. directors and communicating with senior management, proposing senior management team includes several female executives, fully Meanwhile, the Company has established governance mechanisms agendas for special committee meetings, and organizing the embodying gender-diverse leadership. overseen by the Board for key areas such as carbon target setting and discussion on independent-director-related policies and submitting emission reduction practices, compliant operations, risk management recommendations for their revision. This effectively standardizes the The Company prioritizes the development of the Board members’ and corporate culture building, which reflects the its high attention conduct of independent directors, safeguards the overall interests capabilities to fulfill their duties. Focusing on diverse professional and effective leadership toward the sustainable development and of the Group as a listed company, and protects the lawful rights and standardized operations. 示用水印 ※ ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ 示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ ※ 演示用水印 ※20260618 下午 3※ 演示用水印 ※ 示用水印 ※ ※ 演示用水印 ※20260618 下午 ※ 演示 示用水印 ※ 示用水印 ※Stakeholders Stakeholders Expectations Communication and Demands and Response Engagement Compliance operation Operating in compliance with the laws Governments and Regulators Economic development Tax compliance Environmental protection Green operation United Imaging Healthcare formulates the Group’s including governments and regulators, shareholders Social responsibility Response to policies sustainable development strategies largely based on and investors, customers, suppliers and partners, the expectations and demands of all stakeholders. employees, communities, and media. We regularly engage with key stakeholders through Governance structure Standard governance Shareholders diverse communication channels, including As a leading company in high-end medical imaging and Investors Operating performance Profit distribution telephone, email, investor relations interactive and radiotherapy equipment, we consistently Investor relations Information disclosure platforms, and the “Investor Relations” section drive industry upgrading through technological Innovative products R&D and innovation system on the Group’s official website. Our engagement innovation and enhance the accessibility and activities include holding performance briefings, professionalism of medical services. This allows us Product quality Quality and safety system establishment publishing announcements, conducting e-interactive to fulfill our social responsibilities, strengthen our Customers Safety use Responsible marketing Q&A and media interviews, and organizing roadshow core competitiveness, and build a positive corporate Quality service Customer service management and reverse roadshow activities. These efforts image. By working hand in hand with all stakeholders Innovative products R&D and innovation system aim to promote the coordinated development of for mutual benefit, we contribute sustained impetus all parties by earnestly listening to and promptly to the high-quality development of global healthcare. responding to the demands of key stakeholders, Fairness and transparency Fair opportunity Suppliers Double Materiality Assessment United Imaging Healthcare consistently embeds the concept of sustainable development into its long-term corporate strategies, refining its sustainability Process Analysis methodology management practices while ensuring stable business operations. This year, with reference to the SSE Guidelines, we fully gathered stakeholder concerns Assess industry development trends, regulatory requirements, and impacts across the value chain Operating Environment through multiple channels and systematically evaluated topics from two Analysis in light of the Company’s overall strategy, business presence, and financial performance; and dimensions—impact materiality and financial materiality. This assessment was consider the priorities of key stakeholders to analyze material topics from both internal and external supported by methods such as policy trend analysis, industry benchmarking, perspectives. and internal and external expert judgement. The aim was to identify topics material to the Company’s operations and development and to its stakeholders, thereby providing a scientific basis for its strategic decisions and sustainability Identify the impacts, risks, and opportunities associated with relevant topics to form a list of Topic Identification management. This helps us accurately identify the key focuses of ESG material topics, in accordance with the SSE Guidelines and with reference to international management, promoting steady and enduring progress along the sustainability sustainability-related disclosure standards and ESG-rating metrics. journey. procurement, production, warehousing, and transportation, thereby affecting technologies to open up new market opportunities during the transition to a low- product quality and delivery, leading to a decline in revenue and an increase in carbon economy, thereby achieving both environmental benefits and revenue operating costs. growth. Tighter climate change policies may increase compliance costs and operational Adopt energy-efficient production technologies and renewable energy sources; complexity. implement smart manufacturing processes; design modular, easily upgradeable equipment structures; extend equipment service life; and reduce energy consumption and equipment wear and tear. Innovation-Driven Development The development of artificial intelligence and innovative technologies in clinical Promote the development of advanced, high-end medical equipment; optimize trials may raise concerns regarding product safety, medical bias, and information product design innovation, application innovation, and design innovation; and asymmetry, potentially leading to legal disputes, damage to brand reputation, and drive the digital transformation of artificial intelligence and healthcare. adverse effects on product sales and market share. Product Quality and Safety Issues such as product safety and design defects may result in financial losses due High-quality, superior products enhance customer satisfaction, strengthen to product liability claims, which could impact the company’s revenue. brand image and market competitiveness, and drive growth in market share and revenue. Human Capital Development The absence of a comprehensive talent strategy, a diverse and inclusive work A well-developed talent strategy, a diverse, inclusive, and welcoming work environment, a good compensation structure, welfare system and training environment, competitive compensation and incentives, a comprehensive system may result in a lack of employee initiative, low productivity, and increased welfare system and training syetem help boost employee motivation, attract and operating costs. retain top talent, enhance value creation, reduce recruitment costs, and increase business revenue. Business Ethics and Compliant Operations Violations of business ethics or operational regulations, such as embezzlement Comprehensive and transparent management of business ethics, coupled with or bribery, may result in increased operational costs—including legal proceedings sound operational mechanisms, can reduce the likelihood of corruption and Aiming to promote balanced allocation of medical to unlock the potential of medical services at the resources for inclusive health, United Imaging grassroots. We actively share cutting-edge medical Healthcare focuses on making medical services technologies to ensure equal accessibility to global more accessible in county-level regions, advancing medical resources. We also deepen the integration global medical equity, and fostering talent-resource of industry, academia, research, and medical practice synergy, thereby building a multi-tiered, to accelerate the translation of frontier scientific comprehensive healthcare ecosystem. We continue achievements into clinical applications, and to to make dedicated efforts to practice the “Changes systematically cultivate medical professionals.Promoting Accessible Healthcare in Counties In response to the Healthy China Strategy and medical talents, build collaborative diagnostic ※ the “Thousand Counties Project” initiative, capabilities, and enhance the diagnostic we carry out services such as health screenings proficiency and service capacity of county-level and diagnostic support across multiple counties medical institutions. nationwide. These efforts help cultivate grassroots Public Welfare Campaign on Safeguarding Breast Training Workshop Empowers Health—Overcoming Geographic Barriers—Builds County-Level Medical Services a Defense Line for Women’s Health In October 2025, United Imaging Healthcare collaborated technology and expertise to hospitals in remote ethnic As the “capillaries” of the healthcare system, county-level Region. In October 2025, the workshop was successfully with the New Moon Counseling Alliance to launch the regions. hospitals provide diagnosis and treatment services for held in Urumqi. Centered on standard and scientific “Gentle, Courageous, Beautiful” public welfare project nearly 950 million people in China. To continuously medical management, it focused on key areas such focusing on breast health. This project represents a Since 2020, we have partnered with the New Moon enhance their medical service capabilities for as improving equipment efficiency, strengthening the continuation of the Company’s annual series of public Counseling Alliance to deepen our public welfare practice “regeneration” purposes, United Imaging Healthcare diagnosis and treatment capacity for common and major welfare activities and the previous year’s campaign under in safeguarding breast health. By 2025, this campaign proactively fulfills its social responsibilities by providing diseases, advancing smart hospital development, and the same theme. This project incorporated academic had covered five provinces: Yunnan, Xinjiang, Guangdong, ongoing support for the “Special Training Workshop on enhancing epidemic treatment capacity. This program exchanges on cutting-edge imaging technology and free Henan, and Hebei. Supported by diagnosis and treatment the Management and Utilization of Medical Equipment in contributed to the healthy development of tightly knit screening services. Specifically, we conducted academic schemes and specialist forces, we provide superior County-Level Hospitals”. This program is jointly organized county-level medical consortia, effectively addressing seminars, knowledge lectures, and free mammography resources to enhance the regional level of breast-cancer by the International Health Exchange and Cooperation the multi-tiered and high-quality healthcare needs of the screenings, and newly introduced a special workshop diagnosis and treatment. This helps us draw public Center of the National Health Commission (NHC) and the public. on the development of tertiary-hospital specialist attention to the importance of early screening, diagnosis, Health Commission of the Xinjiang Uygur Autonomous departments. These efforts not only disseminated and treatment, thereby strengthening the defense line for breast health knowledge to the public but also delivered women’s health.Promoting Medical Equality Across the Globe United Imaging Healthcare actively responds donations, platform sharing, and technology to the needs of global health governance by transfer, we effectively enhance the accessibility Leading the China-Africa Hospital Alliance to Advance extending its independently innovated high-end and professionalism of local medical services, Health Development in Africa medical equipment and digital-intelligent contributing China’s strength to the equitable diagnostic and treatment solutions to numerous development of the global healthcare sector. countries worldwide. Through financial In August 2025, at the 31st China International Medical intervention. Leveraging China’s independently developed Equipment Exhibition & Scientific Conference, the high-end medical equipment, and supported by AI-assisted China-Africa Hospital Alliance, led by United Imaging diagnosis and information platforms, the alliance works Assisting in Building a “Industrial Talent Chain” Recognizing the critical role of talents in the Since 2022, the Group has participated in the Company’s stable growth, United Imaging Healthcare “Special Pilot for the Reform of Engineering Master Collaborative Development of a Smart Radiotherapy Joint is committed to building a high-caliber medical and Doctoral Student Cultivation” with Shanghai Laboratory - “Qingyun Plan” Promotes Talent Co-Cultivation workforce with professional expertise, innovative Jiao Tong University, Huazhong University of capability, and industry insight. Through systematic Science and Technology, Tongji University, and Xi’an professional training, we continuously empower our Jiaotong University. The first cohort, 8 master’s In December 2025, the signing ceremony for strategic high-end radiotherapy treatment planning systems (TPS) employees to stay abreast of medical technology degree graduates, graduated in 2025, and currently cooperation between United Imaging Healthcare and to establish a high-level teaching-and-practice platform. updates, thereby enabling us to effectively enhance more than 40 graduate students are in training. Southern Medical University, along with the unveiling This helps students master core skills such as target of the “Qingyun Plan”, was held at the Shunde Campus. delineation and dose calculation, enabling a seamless service quality and efficiency. Additionally, we Meanwhile, we conduct joint training and research Both parties signed the Strategic Cooperation Framework integration of theoretical study and clinical practice. As the actively promote an international talent development activities for master’s students with ShanghaiTech Agreement, launching the special initiative for talent first special project implemented, the laboratory will serve program by establishing cross-cultural learning and University, forming an end-to-end cooperation model cultivation—“Qingyun Plan”, and inaugurating the “Smart as an important training base for radiotherapy physicists exchange platforms to lay a solid talent foundation that enables mutual empowerment and supports Radiotherapy Joint Laboratory”. The agreement focuses on in the Guangdong-Hong Kong-Macao Greater Bay Area for the Company’s global expansion and to support talent development and high-quality progress in the areas such as joint R&D of high-end medical equipment, and nationwide. This promotes a deep integration of the construction of key laboratories, cultivation of versatile university-enterprise co-cultivation model and opens a the collaborative advancement of the global medical equipment sector. talents, and transformation of research outputs, all of new pathway for the development of high-caliber and healthcare sector. which contribute to the professional talent pipeline versatile talents. Furthermore, we have established a scientist development. The laboratory is equipped with ten sets of We continue to deepen industry-academia-researc exchange program with Yale University and the h-medical collaboration. Adopting a multi-channel, University of Utah to deepen collaboration on core United Imaging Healthcare regards innovation and R&D as the core driver of corporate development. By safeguarding R&D investment and coordinating the research capabilities of global universities, hospitals, research institutions, and industry partners, we continuously seek to make advanced medical technologies accessible to broader populations. This supports innovation in medical technology R&D and advances breakthroughs as well as widespread adoption of global medical technologies.（未完）  |